Cinnamaldehyde causes apoptosis of myeloid-derived suppressor cells through the activation of TLR4
Wanzhuo He1, Wensheng Zhang2, Qilin Zheng2
1College of Life Sciences, Peking University, Beijing 100871, P.R. China.
Abstract:
Malignant tumors are among the most life-threatening diseases in the world. Although many different types of antitumor agents are available, severe side effects and toxicity limit their applications. Myeloid-derived suppressor cells (MDSCs) inhibit the antitumor immune response by suppressing the proliferation of T cells, the production of cytokines and the killing of tumor cells. As MDSCs have become novel targets in cancer therapy, this research focused on the anti-MDSC function of cinnamaldehyde (CA), which is extracted from cinnamon, a traditional Chinese spice. In the present study, MDSCs isolated from the spleens of mice with colon cancer were used as an in vitro model to assess the efficacy of CA. Treatment of MDSCs with CA significantly decreased cell proliferation and induced apoptotic cell death. Subsequent experiments demonstrated that CA treatment enhanced the expression of Bax and caspase-9 and inhibited the expression of Bcl-2, suggesting that CA induced apoptosis in the MDSCs via the intrinsic pathway. Taken together, the results demonstrated that CA exhibited significant anti-MDSC activity and attenuated the suppression of the antitumor immune response, indicating a potential use for CA in cancer therapy.
Insights
Cinnamaldehyde (CA), derived from cinnamon, effectively reduces myeloid-derived suppressor cells (MDSCs) and enhances antitumor immunity. This natural compound shows promise for novel cancer therapies by targeting immune-suppressing cells.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Malignant tumors pose significant global health risks, with current treatments limited by severe side effects and toxicity.
- Myeloid-derived suppressor cells (MDSCs) critically inhibit effective antitumor immune responses, representing a key therapeutic target in cancer.
- Cinnamaldehyde (CA), a compound from cinnamon, is explored for its potential immunomodulatory and anticancer properties.
Purpose of the Study:
- To investigate the anti-MDSC activity of cinnamaldehyde (CA).
- To evaluate the potential of CA as a therapeutic agent for cancer by assessing its impact on immune suppression mediated by MDSCs.
Main Methods:
- MDSCs were isolated from the spleens of mice with colon cancer to establish an in vitro model.
- The effects of CA treatment on MDSC proliferation and apoptosis were assessed.
- Key apoptosis-related proteins (Bax, Bcl-2, caspase-9) were analyzed to elucidate the mechanism of action.
Main Results:
- CA treatment significantly reduced MDSC proliferation and induced apoptotic cell death in vitro.
- CA enhanced the expression of pro-apoptotic proteins Bax and caspase-9 while downregulating the anti-apoptotic protein Bcl-2.
- These findings suggest CA induces apoptosis in MDSCs via the intrinsic mitochondrial pathway.
Conclusions:
- Cinnamaldehyde (CA) exhibits significant anti-MDSC activity.
- CA treatment attenuates the immunosuppressive function of MDSCs, thereby potentially enhancing the antitumor immune response.
- CA demonstrates potential as a novel therapeutic agent for cancer treatment.
Related Concept Videos
Apoptosis
Differentiation of Common Myeloid Progenitor Cells
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...


